CAC
GLLIW

Cowen and Company’s Globalink Investment Inc. Warrants GLLIW Stock Holding History

Cowen and Company’s Portfolio GLLIW Stock Details GLLIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-245,061
Closed -$6.13K – 539
2024
Q3 		$6.13K Hold
245,061
– – ﹤0.01% 528
2024
Q2 		$12.3K Hold
245,061
– – ﹤0.01% 441
2024
Q1 		$5.88K Buy
245,061
+84,700
+53% +$1.73K ﹤0.01% 558
2023
Q4 		$529 Buy
160,361
+109,245
+214% +$1.32K ﹤0.01% 577
2023
Q3 		$955 Buy
51,116
+100
+0.2% +$2 ﹤0.01% 623
2023
Q2 		$1.02K Buy
51,016
+816
+2% +$15 ﹤0.01% 565
2023
Q1 		$522 Hold
50,200
– – ﹤0.01% 561
2022
Q4 		$552 Buy
50,200
+100
+0.2% +$2 ﹤0.01% 645
2022
Q3 		$3K Hold
50,100
– – ﹤0.01% 557
2022
Q2 		$2K Buy
50,100
+100
+0.2% +$7 ﹤0.01% 623
2022
Q1 		$6K Buy
+50,000
New +$6.7K ﹤0.01% 540

Other funds holding GLLIW

RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
SFM
Spartan Fund Management Toronto, Ontario, Canada $30M AUM 11.98% 1-Year Est. Return

Cowen and Company's GLLIW Position: Q4 2024 in Review

Cowen and Company sold out of Globalink Investment Inc. Warrants (GLLIW) in Q4 2024, closing a stake of 245,061 shares — an estimated $6.13K sold.

Cowen and Company first reported a position in GLLIW in Q1 2022 and held it in 11 quarters. The position peaked at $12.3K in Q2 2024. 4 funds tracked by Wall St. Rank hold GLLIW as of Q4 2024.

  • Cowen and Company reported no remaining Globalink Investment Inc. Warrants position as of Q4 2024 after selling out during the quarter.
  • Cowen and Company sold 245,061 Globalink Investment Inc. Warrants shares in Q4 2024, an estimated $6.13K.
  • Cowen and Company first reported a position in Globalink Investment Inc. Warrants in Q1 2022 and held it in 11 quarters.
  • Cowen and Company's Globalink Investment Inc. Warrants position peaked at $12.3K in Q2 2024.
  • 4 funds tracked by Wall St. Rank held Globalink Investment Inc. Warrants as of Q4 2024.

Based on Cowen and Company's 13F filing for Q4 2024.